{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:14:53Z","timestamp":1791756893691,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.dadr.2022.100074","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T02:27:15Z","timestamp":1656556035000},"page":"100074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Perspectives of people in Philadelphia who use fentanyl\/heroin adulterated with the animal tranquilizer xylazine; Making a case for xylazine test strips"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4367-7076","authenticated-orcid":false,"given":"Megan K.","family":"Reed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas S.","family":"Imperato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette M.","family":"Bowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venise J.","family":"Salcedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Guth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin L.","family":"Rising","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.dadr.2022.100074_bib0001","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/1556-4029.13270","article-title":"Attempted drug-facilitated sexual assault-xylazine intoxication in a child","volume":"62","author":"Andresen-Streichert","year":"2017","journal-title":"J. Forensic Sci."},{"issue":"1","key":"10.1016\/j.dadr.2022.100074_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-021-00546-9","article-title":"Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications","volume":"18","author":"Bowles","year":"2021","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.dadr.2022.100074_bib0003","first-page":"26","article-title":"How the narcs created crack; a war against ourselves","author":"Cowan","year":"1986","journal-title":"Natl. Rev."},{"key":"10.1016\/j.dadr.2022.100074_bib0004","unstructured":"Drug Enforcement Administration. (2021). Xylazine, DEA PRB # 2021-15."},{"key":"10.1016\/j.dadr.2022.100074_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2021.111083","article-title":"Analysis of drug residue in needle-exchange syringes in Washington, D.C","volume":"329","author":"Evans","year":"2021","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.dadr.2022.100074_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109380","article-title":"Xylazine spreads across the US: a growing component of the increasingly synthetic and polysubstance overdose crisis","volume":"233","author":"Friedman","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2022.100074_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2022.111314","article-title":"A survey of the effects of common illicit drugs on forensic DNA analysis","volume":"336","author":"Griffin","year":"2022","journal-title":"Forensic Sci. Int."},{"issue":"9","key":"10.1016\/j.dadr.2022.100074_bib0008","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/1049732305276687","article-title":"Three approaches to qualitative content analysis","volume":"15","author":"Hsieh","year":"2005","journal-title":"Qual Health Res."},{"issue":"4","key":"10.1016\/j.dadr.2022.100074_bib0009","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/injuryprev-2020-043968","article-title":"Increasing presence of xylazine in heroin and\/or fentanyl deaths, Philadelphia, Pennsylvania, 2010\u20132019","volume":"27","author":"Johnson","year":"2021","journal-title":"Inj. Prev."},{"issue":"1","key":"10.1016\/j.dadr.2022.100074_bib0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12954-018-0252-8","article-title":"Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada","volume":"15","author":"Karamouzian","year":"2018","journal-title":"Harm Reduct. J."},{"issue":"37","key":"10.1016\/j.dadr.2022.100074_bib0011","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.15585\/mmwr.mm7037a4","article-title":"Notes from the field: xylazine detection and involvement in drug overdose deaths \u2013 United States, 2019","volume":"70","author":"Kariisa","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.dadr.2022.100074_bib0012","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cca.2021.07.010","article-title":"High prevalence of xylazine among fentanyl screen-positive urines from hospitalized patients, Philadelphia, 2021","volume":"521","author":"Korn","year":"2021","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.dadr.2022.100074_bib0013","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/1556-4029.13684","article-title":"Use of xylazine in drug-facilitated crimes","volume":"63","author":"Krongvorakul","year":"2018","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.dadr.2022.100074_bib0014","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/add.15734","article-title":"Drug checking services for people who use drugs: a systematic review","volume":"117","author":"Maghsoudi","year":"2022","journal-title":"Addiction"},{"key":"10.1016\/j.dadr.2022.100074_bib0015","article-title":"A case of skin necrosis caused by intravenous xylazine abuse","author":"McNinch","year":"2021","journal-title":"Soc. Hosp. Med"},{"key":"10.1016\/j.dadr.2022.100074_bib0016","unstructured":"Mohr, A., Browne, T., Martin, D., & Logan, B. (2020). Xylazine: a toxic adulterant found in illicit street drugs. Retrieved from https:\/\/www.nvopioidresponse.org\/wp-content\/uploads\/2020\/10\/u-public-alert-xylazine-003.pdf."},{"key":"10.1016\/j.dadr.2022.100074_bib0017","unstructured":"Murphy, T. (n.d.). NY State Senate Bill S7397. Retrieved May 16, 2022, from https:\/\/www.nysenate.gov\/legislation\/bills\/2015\/S7397"},{"issue":"1","key":"10.1016\/j.dadr.2022.100074_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13000-015-0279-z","article-title":"Pathologic manifestations of levamisole-adulterated cocaine exposure","volume":"10","author":"Nolan","year":"2015","journal-title":"Diagn. Pathol."},{"issue":"1","key":"10.1016\/j.dadr.2022.100074_bib0019","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/PAF.0000000000000622","article-title":"Xylazine, a veterinary tranquilizer, detected in 42 accidental fentanyl intoxication deaths","volume":"42","author":"Nunez","year":"2021","journal-title":"Am. J. Forensic Med. Pathol."},{"issue":"3","key":"10.1016\/j.dadr.2022.100074_bib0020","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00213-018-5066-6","article-title":"Synthetic cathinone adulteration of illegal drugs","volume":"236","author":"Oliver","year":"2019","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.dadr.2022.100074_bib0021","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugpo.2018.08.007","article-title":"Fentanyl test strips as an opioid overdose prevention strategy: findings from a syringe services program in the Southeastern United States","volume":"63","author":"Peiper","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2022.100074_bib0022","unstructured":"Philadelphia Department of Public Health. (2022). Health alert risks of Xylazine use and withdrawal in people who use drugs in Philadelphia."},{"key":"10.1016\/j.dadr.2022.100074_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103643","article-title":"You can't go wrong being safe\u201d: motivations, patterns, and context surrounding use of fentanyl test strips for heroin and other drugs","volume":"103","author":"Reed","year":"2022","journal-title":"Int. J. Drug Policy"},{"issue":"3","key":"10.1016\/j.dadr.2022.100074_bib0024","first-page":"519","article-title":"The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico","volume":"89","author":"Reyes","year":"2012","journal-title":"J. Urban Health Bull. N. Y. Acad. Med."},{"issue":"3","key":"10.1016\/j.dadr.2022.100074_bib0025","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.drugalcdep.2008.03.005","article-title":"GC\u2013MS confirmation of Xylazine (Rompun), a veterinary sedative, in exchanged needles","volume":"96","author":"Rodr\u00edguez","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2022.100074_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2014.03.015","article-title":"Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: a comprehensive review of the literature","volume":"240","author":"Ruiz-Col\u00f3n","year":"2014","journal-title":"Forensic Sci. Int."},{"issue":"4","key":"10.1016\/j.dadr.2022.100074_bib0027","first-page":"11","article-title":"Xylazine activates adenosine monophosphate-activated protein kinase pathway in the central nervous system of rats","author":"Shi","year":"2016","journal-title":"PLoS One"},{"issue":"37","key":"10.1016\/j.dadr.2022.100074_bib0028","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.15585\/mmwr.mm7037a5","article-title":"Notes from the Field: xylazine, a veterinary tranquilizer, identified as an emerging novel substance in drug overdose deaths \u2014 Connecticut, 2019\u20132020","volume":"70","author":"Thangada","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"3","key":"10.1016\/j.dadr.2022.100074_bib0029","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/CXA.0000000000000089","article-title":"Xylazine identified in the unregulated drug supply in British Columbia, Canada","volume":"11","author":"Tobias","year":"2020","journal-title":"Can. J. Addict."},{"issue":"1","key":"10.1016\/j.dadr.2022.100074_bib0030","first-page":"1","article-title":"Xylazine (veterinary sedative) use in Puerto Rico","volume":"6","author":"Torruella","year":"2011","journal-title":"Subst. Abuse Treat., Prevent. Policy"},{"issue":"2","key":"10.1016\/j.dadr.2022.100074_bib0031","first-page":"68","article-title":"On the relocation of drug users from Puerto Rico to the United States for drug treatment","volume":"24","author":"Torruella","year":"2012","journal-title":"Centro Journal"},{"issue":"2","key":"10.1016\/j.dadr.2022.100074_bib0032","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1556-4029.2007.00648.x","article-title":"Concurrent detection of heroin, fentanyl, and xylazine in seven drug-related deaths reported from the Philadelphia Medical Examiner's Office","volume":"53","author":"Wong","year":"2008","journal-title":"J. Forensic Sci."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724622000488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724622000488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T12:31:08Z","timestamp":1757421068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724622000488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":32,"alternative-id":["S2772724622000488"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2022.100074","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perspectives of people in Philadelphia who use fentanyl\/heroin adulterated with the animal tranquilizer xylazine; Making a case for xylazine test strips","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2022.100074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100074"}}